Inventor
MARTINEZ BOTELLA GABRIEL
US103 patents
⚠️ This page may combine multiple inventors who share the name “MARTINEZ BOTELLA GABRIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SAGE THERAPEUTICS INC
35 patentsUS10246482B2Apr 2, 2019
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC38 citations98
US9725481B2Aug 8, 2017
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC46 citations98
US9512165B2Dec 6, 2016
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC71 citations98
US9365611B2Jun 14, 2016
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC49 citations98
US11241446B2Feb 8, 2022
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC12 citations94
US11149054B2Oct 19, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC14 citations94
US11111266B2Sep 7, 2021
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC15 citations94
US11104701B2Aug 31, 2021
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC16 citations94
US10723758B2Jul 28, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US10696712B2Jun 30, 2020
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC21 citations94
US10342810B2Jul 9, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC17 citations94
US10329320B2Jun 25, 2019
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC18 citations94
US10259840B2Apr 16, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC30 citations94
US10227375B2Mar 12, 2019
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC33 citations94
US10201550B2Feb 12, 2019
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC23 citations94
US10172871B2Jan 8, 2019
19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
SAGE THERAPEUTICS INC20 citations94
US11926646B2Mar 12, 2024
C7 substituted oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11905309B2Feb 20, 2024
Neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11884697B2Jan 30, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11878995B2Jan 23, 2024
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations86
US11780875B2Oct 10, 2023
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC4 citations86
US11732000B2Aug 22, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11613556B2Mar 28, 2023
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC6 citations86
US11542297B2Jan 3, 2023
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11530237B2Dec 20, 2022
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC9 citations86
US11396525B2Jul 26, 2022
C17, C20, and C21 substituted neuroactive steroids and their methods of use
SAGE THERAPEUTICS INC8 citations86
US11344563B2May 31, 2022
19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11261211B2Mar 1, 2022
19-NOR neuroactive steroids and methods of use thereof
SAGE THERAPEUTICS INC8 citations86
US11149057B2Oct 19, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations86
US11124538B2Sep 21, 2021
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC9 citations86
US10870677B2Dec 22, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC13 citations86
US10774108B2Sep 15, 2020
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC12 citations86
US11498940B2Nov 15, 2022
Neuroactive steroids, compositions, and uses thereof
SAGE THERAPEUTICS INC8 citations85
US11407782B2Aug 9, 2022
Oxysterols and methods of use thereof
SAGE THERAPEUTICS INC5 citations84
US11147877B2Oct 19, 2021
Compositions and methods for treating CNS disorders
SAGE THERAPEUTICS INC8 citations84
VERTEX PHARMA
8 patentsUS7767816B2Aug 3, 2010
Azaindoles useful as inhibitors of janus kinases
VERTEX PHARMA44 citations96
US7354939B2Apr 8, 2008
Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto
VERTEX PHARMA52 citations96
US9120790B2Sep 1, 2015
Azaindoles useful as inhibitors of Janus kinases
VERTEX PHARMA14 citations92
US8822681B2Sep 2, 2014
Azaindoles useful as inhibitors of janus kinases
VERTEX PHARMA18 citations92
US7501415B2Mar 10, 2009
Selective inhibitors of ERK protein kinase and uses thereof
VERTEX PHARMA25 citations92
US7358258B2Apr 15, 2008
Prodrugs of an ERK protein kinase inhibitor
VERTEX PHARMA23 citations92
US7244735B2Jul 17, 2007
Heterocyclic protein kinase inhibitors and uses thereof
VERTEX PHARMA39 citations92
US7745629B2Jun 29, 2010
Bicyclic derivatives as modulators of ion channels
VERTEX PHARMA15 citations90
PRAXIS PREC MEDICINES INC
4 patentsUS11014931B2May 25, 2021
3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator
PRAXIS PREC MEDICINES INC18 citations94
US11278535B2Mar 22, 2022
Compounds and their methods of use
PRAXIS PREC MEDICINES INC11 citations85
US11279700B2Mar 22, 2022
Ion channel modulators
PRAXIS PREC MEDICINES INC13 citations85
US11261188B2Mar 1, 2022
Fused heteroaryl compounds, and methods thereof for treating diseases, disorders, and conditions relating to aberrant function of a sodium channel
PRAXIS PREC MEDICINES INC11 citations85
FARMER LUC
2 patentsSALITURO FRANCESCO
1 patentShowing the top 50 of 103 patents by PatentIndex Score.